MAM
Dettol & Treebo Hotels team up to ensure safe stays for guests
NEW DELHI: With the outbreak of the novel Coronavirus, Indians were beset with a zeal for personal and home hygiene products. Hand sanitisers and anti-germ wipes, besides face masks, became mandatory carry-on items for anyone venturing outdoors to combat the deadly pathogen. But like all things, fear, too, passes. People resumed activities that had been put on hold at the height of the pandemic – such as traveling. But Covid is still very much present and poses a threat. A research by Global Monitor indicates that consumers have heightened concerns regarding hygiene on their journey, and trust in cleanliness standards is an extremely critical element when it comes to travel. Clearly, it has become essential for the hospitality sector to implement an effective system to ensure standardised hygiene practices. To this end, Dettol has partnered with Treebo Hotels to facilitate safety and hygiene in domestic travel and create awareness about out of home disinfection and safety.
The partnership program will ensure the use of Dettol products proven effective against the Covid2019 virus to elevate the disinfection and hygiene levels of the hotel premise, and drive regular training of the hotel staff among various other initiatives to ensure that guests enjoy an even cleaner and safer stay at Treebo Hotels.
Dettol will also introduce its recently launched suite of innovative cleanliness products at select Treebo Hotels that will be conferred with the ‘Platinum Hygiene Shield’ for maintaining the highest standards of cleanliness and hygiene.
A Reckitt Benckiser spokesperson said, “As India’s #1 trusted hygiene brand, we aim to partner with our consumers to ensure a healthier environment not just inside, but outside of home as we are at crossroads with the ‘new normal’. We are thrilled to announce our partnership with Treebo hotels in India, as our ethos and priority seamlessly align with one another; providing the safest environment to the Indian population. Through this partnership program we will aim to create a safe, hygienic, and enjoyable experience for its customers with the use of Dettol range of products which are effective against the Covid2019 virus. With this promise, Dettol will continue to drive the organisational purpose and fight in action – to protect, heal, and nurture in the relentless pursuit of a cleaner, healthier world.”
The Treebo Hygiene Shield covers all aspects of safety. Disinfection and safety checks at arrival to contactless check-in, fully disinfected rooms, hand-sanitisers accessible across the property, in-room dining / dining with limited seating in the restaurants, social distancing at the lobby and reception, etc are just some of the aspects of providing guests with completely secured and safe stays. All of these safety and hygiene checks are audited regularly and rigorously by internal and third party experts to arrive at a score of the Treebo Hygiene Shield with Dettol Protection. Based on these scores, the properties are awarded bronze, gold and platinum badges.
Treebo Hotels has also launched the web check-in feature which will further minimise the need for any human interaction at the time of checking-in at a Treebo Hotel. The web check-in feature allows guests to upload ID cards, furnish arrival details, select rooms, and place any other special request up to 48-hours prior to the check-in. Upon arrival at the hotel, guests who have already done a web check-in can just verify their ID cards and collect the keys to their rooms at the reception desk.
Treebo Hotels co-founder Sidharth Gupta said “Dettol is India’s leading hygiene brand. Their partnership with our Covid safety program – Treebo Hygiene Shield – is a great validation of the quality assurance processes we follow, and our obsession about guest experience and safety. Despite the reducing numbers of new cases in India and the hope of mass vaccination on the horizon, we are not taking our eyes off the road and continuing to follow strict hygiene standards at our hotels.”
Treebo hotel partners are optimistic and welcoming of Dettol’s partnership with Treebo Hygiene Shield. Sanket Wetal, who owns and operates three hotels under the Treebo brand across Maharashtra, said, “Dettol usage at Treebo gives the reassurance that our hotel premises are safe and hygienic for guests, visitors and even our own staff. The Dettol protection will become one more reason and a strong validation for guests to pick our hotel.”
Brands
Sun Pharma to acquire Organon in $11.75 billion deal at $14 per share
Acquisition to create $12.4 billion pharma giant with global scale and biosimilars push
MUMBAI: Sun Pharmaceutical Industries Limited has signed a definitive agreement to acquire Organon & Co. in an all-cash deal valued at $11.75 billion, marking one of the largest cross-border pharma acquisitions by an Indian firm.
Under the terms of the agreement, Organon shareholders will receive $14.00 per share in cash, with Sun Pharma set to acquire 100 per cent of the company’s outstanding shares. The transaction, approved by the boards of both companies, is expected to close in early 2027, subject to regulatory approvals and shareholder consent.
The deal significantly expands Sun Pharma’s global footprint and strengthens its position across women’s health, biosimilars, and branded generics. The combined entity is projected to generate revenues of around $12.4 billion, placing it among the top 25 pharmaceutical companies globally.
Organon, which was spun off from Merck in 2021, brings a portfolio of over 70 products spanning women’s health and general medicines, with operations across more than 140 countries. Its established presence in key markets such as the US, Europe, and China complements Sun Pharma’s existing strengths and growth ambitions.
Sun Pharmaceutical Industries Limited executive chairman Dilip Shanghvi said, “This transaction represents a significant opportunity for Sun Pharma to build on its vision of reaching people and touching lives. Organon’s portfolio, capabilities and global reach are highly complementary to our own.”
Sun Pharmaceutical Industries Limited managing director Kirti Ganorkar added, “This transaction is a logical next step in strengthening Sun Pharma’s global business. Together, we will become a partner of choice for acquiring and launching new products.”
From Organon’s side, Organon & Co. executive chair Carrie Cox noted, “This all-cash transaction offers compelling and immediate value to Organon stockholders, while positioning the business for continued growth under Sun Pharma.”
Strategically, the acquisition gives Sun Pharma entry into the global biosimilars space as a top 10 player and strengthens its innovative medicines portfolio, which is expected to contribute around 27 per cent of combined revenues. The deal is also expected to nearly double EBITDA and cash flow, supporting long-term deleveraging and investment capacity.
Sun Pharma plans to fund the acquisition through a mix of internal accruals and committed financing from global banks, while maintaining focus on disciplined integration and operational continuity post-merger.
If completed as planned, the deal signals a clear shift in India’s pharmaceutical ambitions, from scale at home to leadership on the global stage, with Sun Pharma positioning itself as a more diversified and innovation-led healthcare powerhouse.
